rheumatology
JIA

Adalimumab effective in JIA uveitis, but safety concerns exist

Adalimumab in combination with methotrexate is an effective treatment for children with JIA associated uveitis, a study in this week’s NEJM reports. The randomised placebo controlled SYCAMORE trial involving 90 children and adolescents with JIA and active uveitis was stopped early because of a strong beneficial effect in the treatment arm. Overall, at two-year follow ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic